483
Edwin (NMI) DeJesus, M.DFDA 483 - Edwin (NMI) DeJesus, M.D - September 28, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Edwin (NMI) DeJesus, M.D. in Orlando, FL, identified a significant deviation in the conduct of a clinical investigation. The firm failed to adhere to the investigational plan and protocol by enrolling three out of five subjects who did not meet the specified inclusion or exclusion criteria. This indicates a serious breach in clinical trial integrity.
Open in Dashboard
ID · 3115e4c6-39d9-431b-aef9-52dc25fd9d83